美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

减肥药

1,353.23

+18.711.40%

涨家数：7

跌家数：- -

平家数：- -

市盈率：- -

高：1,359.63

开：1,336.29

低：1,333.55

收：1,334.52

数据加载中...

辉瑞(PFE.N)涨近3%。

与诺和诺德达成合作协议 Hims & Hers Health涨超21%

美股异动 | 与诺和诺德(NVO.US)达成合作协议 Hims & Hers Health(HIMS.US)涨超21%

异动 | HIMS飙升逾26%，LFMD大涨逾21%，两家公司均与诺和诺德合作出售减肥药Wegovy

老虎资讯综合

硕迪生物盘中异动股价大涨5.46%报24.91美元

诺和诺德盘中异动早盘快速拉升4.01%报65.13美元

Viking Therapeutics, Inc.盘中异动股价大涨5.36%报27.33美元

BUZZ-辉瑞公司季度利润增长，维持 2025 年业绩预期

辉瑞依靠削减成本抵消收入下降的影响

辉瑞季度销售额不及预期，COVID 治疗收入下降

诺和诺德4月28日成交额为3.93亿美元

安进4月28日成交额为5.89亿美元

欧股“十一罗汉”收盘播报｜诺和诺德收涨将近2.7%，阿斯麦则跌超0.7%

Viking Therapeutics, Inc.盘中异动急速上涨5.04%

诺和诺德肥胖症药物 Wegovy 首次在泰国上市

诺纳生物合作伙伴辉瑞在2025 AACR年会上公布基于TOP1i靶向人间皮素ADC疗法的临床前数据

安进宣布投资9亿美元扩建俄亥俄州生产基地，新增350个工作岗位

安进拟斥9亿美元扩建美国俄亥俄州工厂

数百亿美元！艾伯维、默沙东、安进纷纷宣布投资美国

辉瑞4月25日成交额为8.20亿美元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK4599/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"减肥药","latestPrice":1353.2255,"timestamp":1746043199999,"preClose":1334.5167,"halted":0,"volume":78724328,"delay":0,"changeRate":0.014019,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":18.70874,"latestTime":"04-30 16:00:00 EDT","open":1336.2916,"high":1359.6301,"low":1333.5491,"amount":6796011957.426903,"amplitude":0.019543,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746106200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":10.487449,"peRate":36.838608,"turnoverRate":0.007452,"increases":7,"decrements":0,"flats":0,"marketCap":1447218362912,"floatMarketCap":1361088252576},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1359.6301,"amplitude":0.019543,"preClose":1334.5167,"low":1333.5491,"pbRate":"10.487449","latestPrice":1353.2255,"volume":78724328,"delay":0,"open":1336.2916,"prevYearClose":1305.0607,"prevWeekClose":1313.4298,"prevMonthClose":1353.2255,"prevQuarterClose":1314.3724,"fiveDayClose":1255.0566,"twentyDayClose":1283.6255,"sixtyDayClose":1341.8413,"secType":"PLATE","market":"US","turnoverRate":0.007452,"peRate":36.838608,"marketCap":1447218362912,"floatMarketCap":1361088252576,"timestamp":1746043199999,"nameCN":"减肥药"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":7,"down":0,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2531751539","title":"辉瑞(PFE.N)涨近3%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2531751539","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531751539?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 22:48","pubTimestamp":1745938133,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4568","BK4588","SG9999013999.USD","SG9999002224.SGD","LU0321505439.SGD","SG9999001176.USD","LU0306806265.USD","IE00BBT3K403.USD","BK4599","LU1066051498.USD","LU1066053197.SGD","PFE","SG9999001176.SGD","IE00BLSP4452.SGD","BK4534","IE00B19Z3581.USD","SG9999002232.USD","BK4007","LU0868494617.USD","LU0170899867.USD","LU0225284248.USD","LU0234572021.USD","IE0002270589.USD","LU0456855351.SGD","LU1883839398.USD","IE00B19Z3B42.SGD","BK4533","SG9999003800.SGD","LU1894683348.USD","LU0122379950.USD","LU0058720904.USD","LU1894683264.USD","SG9999011175.SGD","LU1057294990.SGD","IE000M9KFDE8.USD","IE00BLSP4239.USD","BK4550","LU0306807586.USD","LU0289739699.SGD","LU0985481810.HKD","BK4581","LU0321505868.SGD","BK4592","BK4585","LU1023059063.AUD","SGXZ57979304.SGD","LU0225771236.USD"],"gpt_icon":0},{"id":"2531756744","title":"与诺和诺德达成合作协议 Hims & Hers Health涨超21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531756744","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531756744?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 22:04","pubTimestamp":1745935494,"startTime":"0","endTime":"0","summary":"周二，美国远程医疗公司Hims&Hers Health股价拉涨，截至发稿，该股涨超21%，报34.81美元。根据协议内容，诺和诺德旗下的直销平台NovoCare Pharmacy将可通过Hims&Hers网站进行访问，前提是用户需持有Hims&Hers会员身份，且所有剂量版本的Wegovy都将上线。双方表示，此次打包产品的发布只是长期合作的第一步，预计将于本周内在Hims&Hers平台上线。这项合作对总部位于旧金山的Hims&Hers而言是一个关键转折点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429221534a46c4b36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429221534a46c4b36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","IE00BKVL7J92.USD","BK4007","NVO","LU1093756168.USD","LU0154236417.USD","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4585","BK4532","BK4599"],"gpt_icon":1},{"id":"2531753197","title":"美股异动 | 与诺和诺德(NVO.US)达成合作协议 Hims & Hers Health(HIMS.US)涨超21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531753197","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531753197?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 21:55","pubTimestamp":1745934918,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周二，美国远程医疗公司Hims & Hers Health股价拉涨，截至发稿，该股涨超21%，报34.81美元。此前该公司宣布与丹麦制药巨头诺和诺德达成合作协议，将通过其平台销售诺和诺德广受欢迎的减重药物Wegovy。双方表示，此次打包产品的发布只是长期合作的第一步，预计将于本周内在Hims & Hers平台上线。这项合作对总部位于旧金山的Hims & Hers而言是一个关键转折点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287837.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0154236417.USD","BK4007","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4599","NVO","LU1093756325.SGD","HIMS","BK4532","BK4588","LU1093756168.USD","BK4196","BK4585"],"gpt_icon":1},{"id":"1173179156","title":"异动 | HIMS飙升逾26%，LFMD大涨逾21%，两家公司均与诺和诺德合作出售减肥药Wegovy","url":"https://stock-news.laohu8.com/highlight/detail?id=1173179156","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173179156?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 21:48","pubTimestamp":1745934517,"startTime":"0","endTime":"0","summary":"4月26日，截止发稿，HIMS盘中飙升逾26%，LFMD盘中大涨逾21%。消息方面：两家公司均与$诺和诺德(NVO)$合作出售减肥药Wegovy。","market":"us","thumbnail":"https://static.tigerbbs.com/5caed408891c5ae9176e1a31289a0785","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5caed408891c5ae9176e1a31289a0785"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","NVO","HIMS","IE00BZ1G4Q59.USD","LFMD","LU0154236417.USD","BK4585","BK4183","BK4588","BK4599","BK4007","BK4167","LU1093756325.SGD","BK4532","IE00BKVL7J92.USD","BK4196"],"gpt_icon":0},{"id":"2531758632","title":"硕迪生物盘中异动 股价大涨5.46%报24.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531758632","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531758632?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 21:44","pubTimestamp":1745934289,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日21时44分，硕迪生物股票出现异动，股价大幅上涨5.46%。截至发稿，该股报24.91美元/股，成交量4.824万股，换手率0.08%，振幅2.43%。机构评级方面，在所有13家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体跌幅为1.41%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429214449a6cd6d0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429214449a6cd6d0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","BK4007","GPCR"],"gpt_icon":0},{"id":"2531589537","title":"诺和诺德盘中异动 早盘快速拉升4.01%报65.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531589537","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531589537?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 21:31","pubTimestamp":1745933495,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日21时31分，诺和诺德股票出现异动，股价急速上涨4.01%。截至发稿，该股报65.13美元/股，成交量127.066万股，换手率0.03%，振幅0.30%。最近的财报数据显示，该股实现营业收入421.15亿美元，净利润146.46亿美元，每股收益3.29美元，毛利353.13亿美元，市盈率20.66倍。诺和诺德股票所在的制药行业中，整体跌幅为0.18%。其中，阿斯利康重返销冠宝座，诺华大涨超20%。近日，各大跨国药企2024年财报陆续出炉，7家跨国药企在中国的营收也浮出水面。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429213138a46c3f2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429213138a46c3f2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU1093756168.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1093756325.SGD","BK4599","LU0154236417.USD","NVO","BK4532","BK4585","BK4007"],"gpt_icon":1},{"id":"2531737572","title":"Viking Therapeutics, Inc.盘中异动 股价大涨5.36%报27.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531737572","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531737572?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 21:31","pubTimestamp":1745933467,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日21时31分，Viking Therapeutics, Inc.股票出现异动，股价快速拉升5.36%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.78%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。该信息摘要如下：Viking Therapeutics获坎托菲茨杰拉德公司首次覆盖，给予增持评级, 目标价104.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042921310794e79b11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042921310794e79b11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","BK4588","BK4585","VKTX","BK4599"],"gpt_icon":0},{"id":"2531641786","title":"BUZZ-辉瑞公司季度利润增长，维持 2025 年业绩预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2531641786","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531641786?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 19:02","pubTimestamp":1745924560,"startTime":"0","endTime":"0","summary":"** 虽然第一季度营收不及预期，但仍坚持610-640亿美元的财年营收预期 ** 同时，维持 2.80 美元至 3.00 美元的财年每股收益预期。** 截至上次收盘，PFE 年累计下跌约 13 (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nL4T3R7114:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002232.USD","LU0321505868.SGD","LU1023059063.AUD","PFE","BK4585","BK4534","LU1057294990.SGD","SG9999002224.SGD","BK4007","LU0058720904.USD","BK4581","LU0868494617.USD","LU0306807586.USD","SG9999011175.SGD","BK4568","LU1066051498.USD","LU0456855351.SGD","BK4533","SG9999003800.SGD","LU0321505439.SGD","BK4599","LU0122379950.USD","LU1894683348.USD","LU0225771236.USD","BK4550","LU0306806265.USD","BK4592","SG9999013999.USD","IE00BBT3K403.USD","SG9999001176.SGD","LU0289739699.SGD","LU1894683264.USD","LU0170899867.USD","LU1066053197.SGD","LU0985481810.HKD","SG9999001176.USD","IE00B19Z3B42.SGD","SGXZ57979304.SGD","IE00BLSP4239.USD","IE0002270589.USD","LU1883839398.USD","IE000M9KFDE8.USD","IE00B19Z3581.USD","LU0225284248.USD","LU0234572021.USD","BK4588","IE00BLSP4452.SGD"],"gpt_icon":0},{"id":"2531785467","title":"辉瑞依靠削减成本抵消收入下降的影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2531785467","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531785467?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 19:00","pubTimestamp":1745924425,"startTime":"0","endTime":"0","summary":"更新版 6-辉瑞依靠削减成本抵消收入下降的影响辉瑞公布喜忧参半的第一季度业绩，维持全年预期 COVID 疫苗销售好于预期，而抗病毒治疗销售下降预计到 2027 年底可节省 77 亿美元成本 第 8-9 段增加了首席执行官访谈中关于关税的评论Bhanvi Satija/Michael Erman. 路透4月29日 - 辉瑞PFE.N周二表示，公司将通过削减生产和研究业务的成本再节约17亿美元，尽管由于其COVID-19治疗药物Paxlovid的销售下降导致第一季度收入减少，但辉瑞仍强调了其运营效率。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nL4T3R7108:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4588","LU0122379950.USD","LU1066053197.SGD","LU1066051498.USD","IE00BLSP4452.SGD","BK4568","LU1894683264.USD","LU0985481810.HKD","SGXZ57979304.SGD","BK4581","IE00BBT3K403.USD","LU1057294990.SGD","LU0225284248.USD","SG9999001176.USD","IE0002270589.USD","LU1883839398.USD","LU0225771236.USD","LU0868494617.USD","SG9999013999.USD","SG9999002224.SGD","LU0170899867.USD","BK4585","LU0234572021.USD","BK4533","LU0321505868.SGD","BK4550","SG9999011175.SGD","LU0306807586.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","PFE","LU1023059063.AUD","LU0058720904.USD","BK4592","LU0321505439.SGD","SG9999001176.SGD","IE000M9KFDE8.USD","LU0306806265.USD","LU0289739699.SGD","BK4007","BK4599","LU1894683348.USD","SG9999003800.SGD","SG9999002232.USD","LU0456855351.SGD","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2531378394","title":"辉瑞季度销售额不及预期，COVID 治疗收入下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2531378394","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531378394?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 18:49","pubTimestamp":1745923795,"startTime":"0","endTime":"0","summary":"辉瑞季度销售额不及预期，COVID 治疗收入下降路透4月29日 - 美国制药商辉瑞PFE.N周二公布的第一季度收入低于华尔街预期，受其COVID抗病毒治疗药物Paxlovid销售下滑的影响。 LSEG的数据显示，该公司第一季度总营收为137.0亿美元，而分析师预期为139.1亿美元。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nL4S3R70Z5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4592","IE00BBT3K403.USD","LU0170899867.USD","LU0058720904.USD","BK4588","LU0868494617.USD","LU0306806265.USD","BK4581","BK4568","LU1894683264.USD","IE00B19Z3B42.SGD","LU0122379950.USD","BK4599","LU0321505868.SGD","IE00B19Z3581.USD","LU0289739699.SGD","LU0225284248.USD","IE00BLSP4452.SGD","SG9999002224.SGD","BK4533","LU0306807586.USD","BK4585","IE00BLSP4239.USD","LU1883839398.USD","LU1057294990.SGD","LU0234572021.USD","LU0985481810.HKD","LU1066053197.SGD","LU1023059063.AUD","SG9999003800.SGD","SG9999011175.SGD","IE000M9KFDE8.USD","IE0002270589.USD","SG9999013999.USD","BK4534","SG9999002232.USD","LU0321505439.SGD","BK4007","LU0225771236.USD","PFE","SG9999001176.USD","LU0456855351.SGD","SG9999001176.SGD","BK4550","SGXZ57979304.SGD","LU1894683348.USD","LU1066051498.USD"],"gpt_icon":0},{"id":"2531212892","title":"诺和诺德4月28日成交额为3.93亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531212892","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531212892?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 10:13","pubTimestamp":1745892796,"startTime":"0","endTime":"0","summary":"美东时间2025年4月28日，诺和诺德成交额为3.93亿美元，成交额较昨日减少18.75%，当日成交量为628.03万股。诺和诺德于2025年4月28日涨0.87%，报62.62美元，该股过去5个交易日涨7.35%，年初至今跌26.22%，过去60日跌25.63%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429101317a46b510f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429101317a46b510f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","IE00BKVL7J92.USD","BK4585","LU0154236417.USD","BK4532","IE00BZ1G4Q59.USD","NVO","BK4599","LU1093756325.SGD","LU1093756168.USD","BK4588"],"gpt_icon":1},{"id":"2531213559","title":"安进4月28日成交额为5.89亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531213559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531213559?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 09:15","pubTimestamp":1745889357,"startTime":"0","endTime":"0","summary":"美东时间2025年4月28日，安进成交额为5.89亿美元，成交额较昨日增加5.29%，当日成交量为208.25万股。安进于2025年4月28日涨0.8%，报283.09美元，该股过去5个交易日涨3.44%，年初至今涨9.49%，过去60日涨0.48%。安进于 2006 年推出了首款癌症治疗药物 Vectibix，并销售骨强化药物 Prolia/Xgeva和 Evenity。同时，安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429091607a46b3b5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429091607a46b3b5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU2089984988.USD","IE00B2B36J28.USD","LU1023059063.AUD","LU1061106388.HKD","BK4139","LU0122379950.USD","BK4581","BK4588","LU0320765992.SGD","LU0058720904.USD","BK4599","IE0002141913.USD","LU1057294990.SGD","LU0868494617.USD","LU2112291526.USD","LU2468319806.SGD","BK4585","SG9999001440.SGD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU2242652126.USD","LU1983299246.USD","LU0109394709.USD","IE00B4R5TH58.HKD","AMGN","LU2242646821.SGD","BK4533","LU1571399168.USD","LU0889565916.HKD","BK4566","LU0289739699.SGD","BK4534"],"gpt_icon":0},{"id":"2531253847","title":"欧股“十一罗汉”收盘播报｜诺和诺德收涨将近2.7%，阿斯麦则跌超0.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531253847","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531253847?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 01:15","pubTimestamp":1745860542,"startTime":"0","endTime":"0","summary":"周一，阿斯麦控股荷兰阿姆斯特丹股价收跌0.75%，报584.50欧元。诺和诺德哥本哈根股价收涨2.68%，报414.30。德国思爱普Sap、葛兰素史克、欧莱雅、罗氏制药、阿斯利康、雀巢涨1.68%-1.18%，诺华、赛诺菲、LVMH集团至多涨0.93%。在欧洲奢侈品概念股中，博柏利、雨果博斯、开云集团涨2.94%-2.29%。在意大利银行股中，Banca Sistema SpA.涨6.2%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042901181294e62c08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042901181294e62c08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0097036916.USD","03165","LU1093756168.USD","IE0004445239.USD","IE00BKVL7J92.USD","ASML","BK4147","LU1734074674.USD","LU0823434583.USD","BK4532","LU1093756325.SGD","NVO","BK4585","IE00BD6J9T35.USD","BK4007","BK4588","IE00BZ1G4Q59.USD","LU0823434740.USD","LU0154236417.USD","LU2063271972.USD","LU0345774391.USD","LU0345774631.USD","BK4543","BK4599"],"gpt_icon":0},{"id":"2530228954","title":"Viking Therapeutics, Inc.盘中异动 急速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530228954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530228954?lang=zh_cn&edition=fundamental","pubTime":"2025-04-28 21:43","pubTimestamp":1745847819,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日21时43分，Viking Therapeutics, Inc.股票出现波动，股价大幅拉升5.04%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。其相关个股中，Galmed Pharmaceuticals Ltd.、Cg Oncology, Inc.、Portage Biotech Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Portage Biotech Inc.、Tharimmune, Inc.较为活跃，换手率分别为1597.19%、344.10%、66.30%，振幅较大的相关个股有Galmed Pharmaceuticals Ltd.、Protara Therapeutics, Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为27.39%、22.69%、22.50%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428214340a6cbc313&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428214340a6cbc313&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","VKTX","BK4599","BK4007","LENZ","BK4139","BK4585"],"gpt_icon":0},{"id":"2530242608","title":"诺和诺德肥胖症药物 Wegovy 首次在泰国上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2530242608","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530242608?lang=zh_cn&edition=fundamental","pubTime":"2025-04-28 17:01","pubTimestamp":1745830918,"startTime":"0","endTime":"0","summary":"路透曼谷4月28日 - 丹麦诺和诺德NOVOb.CO公司当地子公司的一位高管周一表示，该公司已在泰国推出了大受欢迎的减肥药Wegovy，这标志着该注射药物首次进入东南亚市场。Bruland拒绝透露Wegovy在泰国的定价细节，也拒绝透露诺和诺德进军其他东南亚市场的计划。Bruland说，Wegovy目前在泰国各地的私立医院有处方药出售，不久将在公立医院上市。诺和诺德的糖尿病药物 Ozempic 与 Wegovy 的活性成分相同，已经在泰国上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nL4S3R60O2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0004445239.USD","LU0109391861.USD","LU1127390331.HKD","SGXZ51526630.SGD","IE00BJT1NW94.SGD","LU0882574055.USD","LU2461242641.AUD","LU1023059063.AUD","LU1623119135.USD","LU2471134879.HKD","LU0640476718.USD","LU2237443549.SGD","BK4581","LU2491049909.HKD","SG9999015952.SGD","SGXZ99366536.SGD","LU1983299246.USD","SG9999015986.USD","LU1868836591.USD","BK4588","BK4599","LU0943347566.SGD","LU2471134952.CNY","LU0203201768.USD","LU0203202063.USD","LU2264538146.SGD","BK4534","LU1712237335.SGD","LU1988902786.USD","LU2063271972.USD","LU1868837136.USD","LU0256863811.USD","LU2112291526.USD","LU1551013342.USD","LU0672654240.SGD","SG9999014914.USD","IE00B2B36J28.USD","LU0456855351.SGD","SG9999015978.USD","LU0823416689.USD","LU0198837287.USD","IE00BK4W5M84.HKD","BK4007","LU0097036916.USD","LU0058720904.USD","LU2491050071.SGD","LU1804176565.USD","LU1069344957.HKD","LU2106854487.HKD"],"gpt_icon":1},{"id":"2530497866","title":"诺纳生物合作伙伴辉瑞在2025 AACR年会上公布基于TOP1i靶向人间皮素ADC疗法的临床前数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2530497866","media":"医药魔方","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530497866?lang=zh_cn&edition=fundamental","pubTime":"2025-04-28 08:31","pubTimestamp":1745800285,"startTime":"0","endTime":"0","summary":"诺纳生物，一家致力于前沿技术创新，并为合作伙伴提供涵盖靶点验证和新一代生物大分子药物从发现至临床前研发等Idea to IND完整服务的国际化创新生物技术公司，今日宣布其合作伙伴辉瑞在2025年美国癌症研究协会年会上公布了同类首创基于拓扑异构酶1抑制剂的靶向人间皮素抗体偶联药物PF-08052666的临床前数据。2023年12月14日，辉瑞获得了其全球临床开发和商业化权利。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428102605a469cf3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428102605a469cf3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1894683348.USD","SG9999001176.SGD","IE000M9KFDE8.USD","LU0985481810.HKD","LU0306806265.USD","BK4231","LU0321505439.SGD","LU1057294990.SGD","LU1066051498.USD","LU0225284248.USD","BK4599","LU0321505868.SGD","BK4080","BK4568","LU1066053197.SGD","LU1894683264.USD","PFE","SG9999013999.USD","LU0170899867.USD","BK4581","IE00BBT3K403.USD","LU0122379950.USD","LU0234572021.USD","BK4550","BK4534","BK4592","SG9999002232.USD","LU0868494617.USD","LU1883839398.USD","BK4533","SG9999003800.SGD","LU0289739699.SGD","IE0002270589.USD","IE00BLSP4239.USD","LU0058720904.USD","BK4585","LU0306807586.USD","SG9999001176.USD","SGXZ57979304.SGD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","SG9999011175.SGD","LU1023059063.AUD","LU0225771236.USD","BK4007","BK4588","SG9999002224.SGD","ADC","LU0456855351.SGD"],"gpt_icon":1},{"id":"2530454984","title":"安进宣布投资9亿美元扩建俄亥俄州生产基地，新增350个工作岗位","url":"https://stock-news.laohu8.com/highlight/detail?id=2530454984","media":"药事纵横","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530454984?lang=zh_cn&edition=fundamental","pubTime":"2025-04-28 00:03","pubTimestamp":1745769792,"startTime":"0","endTime":"0","summary":"2025年4月25日，安进公司对外宣布，该公司将对其俄亥俄州生产基地追加9亿美元投资，使该州累计新增就业岗位达750个，在中俄亥俄州总投资额超过14亿美元。此次投资进一步彰显我们对扩大美国生产基地的承诺，确保全球患者能持续获得创新药物。\"安进于2021年6月首次进驻俄亥俄州，宣布在中俄亥俄州建设尖端生物制药基地。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428002754a4695b56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428002754a4695b56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1571399168.USD","LU1061106388.HKD","BK4581","LU0320765992.SGD","LU2089984988.USD","LU1023059063.AUD","LU0058720904.USD","LU2468319806.SGD","LU2242652126.USD","SG9999001440.SGD","LU0289739699.SGD","BK4534","IE00BFTCPJ56.SGD","BK4139","BK4585","IE0002141913.USD","LU0122379950.USD","BK4566","LU2112291526.USD","LU1983299246.USD","IE00BJJMRZ35.SGD","BK4533","LU1057294990.SGD","IE00B2B36J28.USD","BK4599","LU0889565916.HKD","LU0868494617.USD","LU0109394709.USD","LU2242646821.SGD","AMGN","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","IE0009355771.USD","BK4588"],"gpt_icon":0},{"id":"2530193102","title":"安进拟斥9亿美元扩建美国俄亥俄州工厂","url":"https://stock-news.laohu8.com/highlight/detail?id=2530193102","media":"格隆汇APP","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530193102?lang=zh_cn&edition=fundamental","pubTime":"2025-04-27 11:08","pubTimestamp":1745723280,"startTime":"0","endTime":"0","summary":"格隆汇4月27日｜制药公司安进周五表示，将投资9亿美元扩建美国俄亥俄州的制造工厂，料增加350个工作岗位。去年12月，安进宣布斥资10亿美元在北卡罗来纳州霍利斯普林斯建造第二间原料药厂。               \n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2025-04-27/doc-ineuqqcx0040528.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1061106388.HKD","SG9999001440.SGD","LU1057294990.SGD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU1571399168.USD","AMGN","BK4585","IE00BFTCPJ56.SGD","LU0058720904.USD","LU0122379950.USD","BK4581","BK4534","LU2242646821.SGD","LU2242652126.USD","LU2112291526.USD","BK4566","IE0002141913.USD","BK4599","LU0109394709.USD","LU0320765992.SGD","LU1023059063.AUD","IE0009355771.USD","BK4139","LU1983299246.USD","IE00BJT1NW94.SGD","BK4533","LU2089984988.USD","LU2468319806.SGD","LU0289739699.SGD","LU0868494617.USD","LU0889565916.HKD","BK4588","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"2530279141","title":"数百亿美元！艾伯维、默沙东、安进纷纷宣布投资美国","url":"https://stock-news.laohu8.com/highlight/detail?id=2530279141","media":"Medaverse","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530279141?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 20:44","pubTimestamp":1745671472,"startTime":"0","endTime":"0","summary":"4月25日，由于药品进口关税可能会刺激美国对生命科学的投资热潮，艾伯维也加入了这一趋势，计划在未来十年内在美国投资100亿美元。在此之前，诺华、礼来和强生已作出重大承诺，将扩大其在美国的足迹，并公布了230亿至550亿美元的投资。艾伯维报告称2025年第一季度收入为133.4亿美元，同比增长8.4%。Rinvoq也表现良好，销售额增长57%，达到17亿美元。Humira目前仅占AbbVie总收入的8%，环比下降3%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426234320a6c96fda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426234320a6c96fda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4516","LU1974910355.USD","BK4588","LU1066051811.HKD","SG9999013999.USD","SG9999002224.SGD","IE00BJJMRZ35.SGD","LU1035773651.USD","LU1917777945.USD","BK4599","LU1116320737.USD","LU1934455194.USD","LU0211331839.USD","LU1037948541.HKD","LU1066053197.SGD","LU0320765489.SGD","LU1934455277.USD","IE00BJT1NW94.SGD","LU0203347892.USD","LU0238689110.USD","IE00BLSP4452.SGD","LU1093756325.SGD","BK4007","AMGN","LU2023250843.SGD","LU2112291526.USD","LU2089984988.USD","MRK","LU1061106388.HKD","BK4533","SG9999014567.USD","LU1585245621.USD","LU1983299246.USD","LU0965508806.USD","IE00BSNM7G36.USD","LU0965509101.SGD","LU2242652126.USD","LU1162221912.USD","IE00BN8TJ469.HKD","LU2361045086.USD","LU0985320562.USD","LU1941712264.USD","LU2242646821.SGD","ABBV","LU0203345920.USD","SG9999015358.SGD","LU1989772840.SGD","LU0109394709.USD","SGXZ57979304.SGD","LU0266013472.USD","LU2361044949.HKD"],"gpt_icon":0},{"id":"2530772119","title":"辉瑞4月25日成交额为8.20亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530772119","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530772119?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 10:18","pubTimestamp":1745633897,"startTime":"0","endTime":"0","summary":"美东时间2025年4月25日，辉瑞成交额为8.20亿美元，成交额较昨日增加3.34%，当日成交量为3584.77万股。辉瑞于2025年4月25日涨0.61%，报22.92美元，该股过去5个交易日涨3.52%，年初至今跌12.18%，过去60日跌13.9%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-25|8.20亿|3.34%|3584.77万|#|2025-04-24|7.94亿|-30.67%|3500.96万|#|2025-04-23|11.45亿|41.51%|5078.10万|#|2025-04-22|8.09亿|14.76%|3605.26万|#|2025-04-21|7.05亿|-41.56%|3202.10万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426101825a46793a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426101825a46793a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999011175.SGD","LU0306807586.USD","IE00B19Z3581.USD","LU1057294990.SGD","LU1894683348.USD","BK4585","BK4592","BK4007","IE000M9KFDE8.USD","SG9999002224.SGD","BK4568","IE00BLSP4452.SGD","LU0058720904.USD","LU0122379950.USD","BK4581","LU0225284248.USD","LU0985481810.HKD","BK4550","BK4534","IE00B19Z3B42.SGD","LU1066053197.SGD","LU1883839398.USD","LU1066051498.USD","LU0321505868.SGD","IE00BBT3K403.USD","SG9999001176.USD","LU0234572021.USD","SG9999001176.SGD","LU0306806265.USD","SG9999002232.USD","LU1894683264.USD","BK4599","IE0002270589.USD","SG9999013999.USD","IE00BLSP4239.USD","LU0170899867.USD","LU0225771236.USD","LU1023059063.AUD","SG9999003800.SGD","BK4533","LU0289739699.SGD","SGXZ57979304.SGD","LU0868494617.USD","BK4588","PFE","LU0456855351.SGD","LU0321505439.SGD"],"gpt_icon":1}],"pageSize":20,"totalPage":7,"pageCount":2,"totalSize":123,"code":"91000000","status":"200"}]}}